The role of combined fludarabine, cyclophosphamide and rituximab chemoimmunotherapy in chronic lymphocytic leukemia: current evidence and controversies.
- Published in:
- Therapeutic Advances in Hematology, 2017, v. 8, n. 3, p. 99, doi. 10.1177/2040620716681749
- By:
- Publication type:
- Article